Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
LiveOne (Nasdaq: LVO) Reports Q3 Fiscal Year 2024 Record Revenue of $31.2M and Adjusted EBITDA* of $3.3M, Memberships Increased 687K (+36% YoY)
-
PodcastOne Reports Revenue of $31.6M (+22% YoY) and Adjusted EBITDA* of $405K for First Nine Months Fiscal 2024
-
Trace Genomics CEO & Co-Founder Poornima Parameswaran Elected to the International Myeloma Foundation’s Board of Directors
-
AITX’s RAD Announces First Municipal RADDOG Adoption
-
Form 8.3 - Young & Co's Brewery plc
-
Dev Kit Updates Unlock New Potential for User Generated Content in ARK Survival Ascended
-
Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing
-
Valoe’s Financial Information and Annual General Meeting in 2024
-
Spod Lithium Preparing Upcoming Drill Program Following Positive Results From Fall Prospecting
-
Live Ventures Reports Fiscal First Quarter 2024 Financial Results
-
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
-
Supremex Announces Date of its 2023 Fourth Quarter Results Conference Call
-
AISIX SOLUTIONS TO ADVANCE DEPLOYMENT OF CUTTING-EDGE AI SOFTWARE FOR ENHANCED IFRS S1 AND S2 COMPLIANCE REPORTING
-
Systemic Bio to Present Innovative Human-relevant Datasets from h-VIOS™ Platform at SOT and AACR 2024 Annual Meetings
-
Ohmyhome Announces Growth Updates Following Successful Acquisition of Property Management Business Simply Sakal
-
SharpLink Gaming Regains Full Compliance with Nasdaq Continued Listing Standards
-
Trinity Biotech to Present at Emerging Growth Conference
-
KraneShares Launches Defined Outcome ETFs (Tickers: KPRO, KBUF) For China Internet Exposure On The New York Stock Exchange
-
Arrive Partners With AllMart Marketplace to Launch Its Smart Mailbox Solution in Antigua
-
Golden Grail Beverages (OTC: GOGY) Nears Extension of Partnership with NASCAR Xfinity Series Full-Time Driver Ryan Ellis
-
Thea Energy Announces $20 Million Series A Financing
-
Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device
-
Stellar Line-up at Qlik Connect 2024 Charts Future of Data and AI
-
Rackspace Technology Appoints Experienced and Seasoned Executive Mark Gross to Board of Directors
-
MGP Ingredients Schedules Fourth Quarter and Full Year 2023 Conference Call/Webcast for Thursday, February 22
-
Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients
-
Issue of Equity
-
Forbes Names Demio “Best Webinar Tool for Marketers”
-
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
-
Man Group PLC : Form 8.3 - Barrat Developments plc
-
Solera Announces Leadership Transition
-
Blink Charging Chosen by City of Frederick, Maryland, for Downtown Electric Vehicle Charging Solutions
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
NFI Announces Chief Financial Officer Transition
-
Stronghold Announces January Bitcoin Mining and Carbon Capture Update
-
Nexterus Emcees Panel of Supply Chain Executives discussing “Navigating the Complexities of Global Supply Chains”
-
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
-
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
-
Majority of Ontarians wagering on Super Bowl LVIII to bet online
-
Microchip Earns Certification in ISO/SAE 21434 Road Vehicle—Cybersecurity Engineering Standard from UL Solutions
-
Harfang Acquires 100% Interest in the Egan Gold Property
-
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
-
Tenaya Therapeutics Announces Pricing of Underwritten Offering
-
Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
-
HUB Cyber Security and Blackswan Tech Team Up for $3.2M Deal with a Top-Tier European Bank
-
Mineralys Therapeutics Announces $120 Million Private Placement Financing
-
Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom in the New England Journal of Medicine
-
Refined Metals Corp. Announces Change to Executive Management
-
Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders
-
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination Product
